GeneQuantum Healthcare (Suzhou) Co., Ltd.
4 clinical trials · Sponsor
◉ Watch GeneQuantum Healthcare (Suzhou) Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Trial Comparing GQ1005 and T-DM1 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer (NCT07673029) | GeneQuantum Healthcare (Suzhou) Co., Ltd. | 2025-01-10 |
| A Study of GQ1010 in Subjects With Advanced Solid Tumors (NCT06464055) | GeneQuantum Healthcare (Suzhou) Co., Ltd. | 2024-05-23 |
| A Study of GQ1005 in Subjects With HER2-Expressing Advanced Solid Tumors (NCT06154343) | GeneQuantum Healthcare (Suzhou) Co., Ltd. | 2022-11-23 |
| Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors (NCT04450732) | GeneQuantum Healthcare (Suzhou) Co., Ltd. | 2020-07-07 |
Track GeneQuantum Healthcare (Suzhou) Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.